Unraveling the complexity of circulating forms of brain natriuretic peptide

Clinical Chemistry

Volumn 53, Issue 7, 2007, Pages 1181-1182

  Gundry, Rebekah L ^a   Van Eyk, Jennifer E ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Center Tower ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CARRIER PROTEIN; HORMONE PRECURSOR; PLASMA PROTEIN; TROPONIN C; TROPONIN I;

ANALYTIC METHOD; ANIMAL CELL; ANTIGEN BINDING; CHO CELL; CLINICAL LABORATORY; EDITORIAL; GLYCOSYLATION; HUMAN; IMMUNOASSAY; MAMMAL CELL; MASS SPECTROMETRY; MOLECULAR WEIGHT; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; HEART FAILURE, CONGESTIVE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS;

EID: 34347397358     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2007.086611     Document Type: Editorial

References (15)

1. Seferian K, Semenov TN, Mukharyamova KS, Tolstaya AA, Koshkina EV, Kara AN, et al. The brain natriuretic peptide precursor (proBNP) is the major immunoreactive form of BNP in patients with heart failure. Clin Chem 2007;53:866-73.
2. Schellenberger U, O'Rear J, Guzzetta A, Jue RA, Protter AA, Pollitt NS. The precursor to B-type natriuretic peptide is an O-linked glycoprotein. Arch Biochem Biophys 2006;451:160-6.
3. Gundry R, Fu Q, Jelinek C, Van Eyk J, Cotter R. Investigation of an albumin-enriched fraction of human serum and its albuminome. Proteomics 2007;1:73-88.
4. Camerini S, Polci M, Liotta L, Petricoin E, Zhou W. A method for the selective isolation and enrichment of carrier protein-bound low-molecular weight proteins and peptides in the blood. Proteomics 2007;1:176-84.
5. Petricoin EF, Belluco C, Araujo RP, Liotta LA. The blood peptidome: a higher dimension of information content for cancer biomarker discovery 2006;6:961-7.
6. Labugger R, Simpson JA, Quick M, Brown HA, Collier CE, Neverova I, et al. Strategy for analysis of cardiac troponins in biological samples with a combination of affinity chromatography and mass spectrometry. Clin Chem 2003;49:873-9.
7. Hortin GL. A New era in protein quantification in clinical laboratories: application of liquid chromatography-tandem mass spectrometry. Clin Chem 2007;53:543-4.
8. Anderson L, Hunter CL Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins. Mol Cell Proteomics 2006;5:573-88.
9. Bondar OP, Barnidge DR, Klee EW, Davis BJ, Klee GG. LC-MS/MS quantification of Zn-alpha2 glycoprotein: a potential serum biomarker for prostate cancer. Clin Chem 2007;53:673-8.
10. Barnidge DR, Goodmanson MK, Klee GG, Muddiman DC. Absolute quantification of the model biomarker prostate-specific antigen in serum by LC-Ms/MS using protein cleavage and isotope dilution mass spectrometry. J Proteome Res 2004;3:644-52.
11. Wu SL, Amato H, Biringer R, Choudhary G, Shieh P, Hancock WS. Targeted proteomics of low-level proteins in human plasma by LC/MSn: using human growth hormone as a model system. J Proteome Res 2002;1:459-65.
12. Kuhn E, Wu J, Karl J, Liao H, Zolg W, Guild B. Quantification of C-reactive protein in the serum of patients with rheumatoid arthritis using multiple reaction monitoring mass spectrometry and 13C-labeled peptide standards. Proteomics 2004;4:1175-86.
13. Nedelkov D, Kiernan UA, Niederkofler EE, Tubbs KA, Nelson RW. Population proteomics: the concept, attributes, and potential for cancer biomarker research. Mol Cell Proteomics 2006;5:1811-8.
14. Jaffe AS, Van Eyk JE. Troponin fragments-diagnostic potential? In: Morrow D, ed. Cardiovascular Biomarkers: Pathology and Disease Management, Contemporary Cardiology Series, 2006:161-76.
15. McDonough JL, Van Eyk JE. Developing the next generation of cardiac markers: disease-induced modifications of troponin I. Prog Cardiovasc Dis 2004;47:207-16.